We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · March 26, 2023

Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in Patients With Type 2 Diabetes

Diabetes Care

 

Additional Info

Diabetes Care
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Diabetes Care 2023 Mar 01;[EPub Ahead of Print], S Abdelgani, A Khatab, J Adams, M Abu-Farha, G Daniele, F Al-Mulla, S Del Prato, RA DeFronzo, M Abdul-Ghani

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading